![]() |
市場調查報告書
商品編碼
1904617
精準發酵和細胞培養食品市場預測至2032年:按產品類型、形態、生產方法、技術、應用、最終用戶和地區分類的全球分析Precision Fermentation & Cell-Cultured Food Market Forecasts to 2032 - Global Analysis By Product Type, Form, Production, Technology, Application, End User and By Geography |
||||||
根據 Stratistics MRC 的一項研究,全球精準發酵和細胞培養食品市場預計到 2025 年將價值 49 億美元,到 2032 年達到 516.5 億美元,在預測期內複合年成長率為 40.0%。
精準發酵和細胞培養食品是利用可控生物製程生產食品配料和產品的創新生物技術方法。精準發酵透過操控微生物來生產特定的化合物,例如蛋白質和脂肪;而細胞培養食品則透過培養動物細胞來生產肉類和乳製品,無需飼養牲畜。這些技術永續、資源更有效率的食品生產,減少對傳統農業的依賴,並確保產品品質穩定,因此是滿足未來世界蛋白質和營養需求的關鍵解決方案。
對替代蛋白質的需求日益成長
人們對環境永續性、動物福利和食品安全的日益關注,正加速推動對非傳統蛋白質來源的興趣。傳統畜牧業因其溫室氣體排放量高、資源消耗大而備受批評,促使人們採用新型蛋白質技術。精準發酵技術能夠生產出品質穩定、環境影響小的功能性蛋白質。同時,細胞培養食品在滿足日益成長的蛋白質需求的同時,也解決了與動物屠宰相關的倫理問題。食品生物技術的進步提高了產品的可擴展性和安全性,增強了消費者的信任。隨著彈性素食和氣候友善飲食的日益普及,全球對新一代蛋白質解決方案的需求持續成長。
高昂的生產成本
此製程需要昂貴的反應器、培養基和嚴格的品管系統,增加了資本支出。將實驗室製程放大到商業化生產規模面臨巨大的技術和資金挑戰。能源消耗和設施維護進一步增加了營運成本,限制了其與傳統食品的價格競爭。監管合規和食品安全檢驗也增加了總支出。小規模公司往往難以獲得資金籌措來支持漫長的研發週期。在成本效益提高之前,高昂的價格可能會阻礙其被大眾市場接受。
雜交食品的興起
混合食品將精準發酵或細胞培養的成分與植物來源成分結合,以改善口感、質地和營養價值。這種方法減少了對昂貴培養成分的依賴,同時提高了消費者的接受度。食品製造商正在利用混合配方加快產品上市速度並控制生產成本。成分配方的創新也使得產品能夠根據特定的膳食需求和烹飪用途進行客製化。混合產品的監管流程通常比完全培養食品更簡單,從而加快了上市速度。隨著對價格合理且永續的蛋白質替代品的需求不斷成長,混合解決方案正吸引業界的廣泛關注。
供應鏈脆弱性
此領域高度依賴培養基、微生物菌株和生物加工設備等專用投入品。原料供應中斷會導致生產延誤和成本增加。由於全球生物技術組件來源有限,依賴性風險加劇。運輸瓶頸和地緣政治不確定性也對物流網路帶來額外壓力。各公司正積極探索在地化生產和垂直整合以應對這些挑戰。如果沒有穩健的供應鏈策略,營運規模化和及時商業化可能會受到限制。
新冠疫情對精準發酵和細胞培養食品產業產生了重大影響。封鎖和貿易限制擾亂了研究活動、中試生產和全球供應鏈。不確定性影響了資金籌措優先事項,導致投資流動暫時放緩。然而,疫情凸顯了傳統肉類供應鏈的脆弱性,並提高了人們對具有韌性的食品體系的關注。消費者對食品安全、可追溯性和永續性的關注增強了對替代蛋白的支持。疫情過後,各國政府和私人投資者恢復了對食品創新和生物技術的支持。因此,儘管短期內業務受到干擾,但長期市場前景有所改善。
預計在預測期內,培養肉細分市場將佔據最大的市場佔有率。
由於與傳統動物蛋白質高度相似,預計在預測期內,培養肉將佔據最大的市場佔有率。培養肉不僅口感、質地和營養成分與傳統動物肉相似,也避免了畜牧業帶來的環境負擔。大型食品公司和創業投資不斷增加的投資正在加速產品研發。部分地區的監管核准正在提升市場信譽度和商業化前景。細胞株開發和反應器效率的提升提高了生產的可行性。隨著透明度和消費者認知度的提高,人造肉的接受度也逐漸提高。
預計在預測期內,替代蛋白品牌細分市場將呈現最高的複合年成長率。
預計在預測期內,替代蛋白品牌細分市場將實現最高成長率。各品牌正大力投資行銷、產品創新和消費者互動。強大的品牌影響力有助於建立消費者對精準發酵和發酵食品等新技術的信任。與直銷 (D2C) 和餐飲服務業的合作正在擴大品牌知名度。產品快速多元化,包括零食、乳製品替代品和機能性食品,正在推動銷售成長。此外,各品牌也透過強調永續性來吸引年輕消費族群。
由於北美地區擁有強大的創新生態系統,預計該地區將在預測期內佔據最大的市場佔有率。該地區受惠於先進的生物技術基礎和雄厚的研發投入。眾多領先的Start-Ups、研究機構和成熟的食品公司為快速商業化提供了支持。良好的資金籌措環境和創業投資活動正在加速技術突破。監管機構正逐步完善新型食品核准框架。消費者對替代蛋白的高度認知和接受意願進一步鞏固了其市場領導地位。
由於人口成長和蛋白質需求上升,預計亞太地區在預測期內將實現最高的複合年成長率。快速的都市化和收入成長正在改變全部區域的飲食習慣。各國政府正加強對糧食安全和永續蛋白質舉措的支持。中國、新加坡和日本等國正在投資細胞農業和發酵技術。某些市場的監管發展正在推動試點項目和商業化。本地製造商正與全球創新者合作,以加速技術的應用。
According to Stratistics MRC, the Global Precision Fermentation & Cell-Cultured Food Market is accounted for $4.90 billion in 2025 and is expected to reach $51.65 billion by 2032 growing at a CAGR of 40.0% during the forecast period. Precision Fermentation & Cell-Cultured Food encompasses innovative methods that leverage biotechnology to produce food ingredients and products through controlled biological processes. Precision fermentation engineers microbes to generate targeted compounds such as proteins or fats, whereas cell-cultured food involves cultivating animal cells to create meat or dairy without raising livestock. These technologies support more sustainable, resource-efficient food production, lower dependence on traditional agriculture, and enable consistent quality, making them key solutions for future global protein and nutrition demands.
Rising demand for alternative proteins
Increasing awareness of environmental sustainability, animal welfare, and food security is accelerating interest in non-traditional protein sources. Conventional livestock farming faces criticism due to high greenhouse gas emissions and resource intensity, encouraging adoption of novel protein technologies. Precision fermentation enables the production of functional proteins with consistent quality and reduced environmental impact. Meanwhile, cell-cultured foods address ethical concerns associated with animal slaughter while meeting rising protein needs. Advancements in food biotechnology are improving scalability and product safety, strengthening consumer trust. As flexitarian and climate-conscious diets gain popularity, demand for next-generation protein solutions continues to expand globally.
High production costs
The process requires expensive bioreactors, growth media, and stringent quality control systems, increasing capital expenditure. Scaling laboratory processes to commercial production presents significant technical and financial challenges. Energy consumption and facility maintenance further elevate operating costs, limiting price competitiveness with conventional foods. Regulatory compliance and food safety validation also add to overall expenditure. Smaller companies often struggle to secure sufficient funding to support long development cycles. Until cost efficiencies improve, high prices may restrict mass-market adoption.
Advancements in hybrid food products
Hybrid foods combine precision-fermented or cell-cultured ingredients with plant-based components to enhance taste, texture, and nutritional value. This approach reduces reliance on costly cultured inputs while improving consumer acceptance. Food manufacturers are leveraging hybrid formulations to accelerate commercialization and manage production expenses. Innovation in ingredient blending is also enabling customization for specific dietary needs and culinary applications. Regulatory pathways for hybrid products are often simpler than for fully cultured foods, supporting faster market entry. As demand for affordable and sustainable protein alternatives rises, hybrid solutions are gaining strong industry interest.
Supply chain vulnerabilities
The sector relies heavily on specialized inputs such as growth media, microbial strains, and bioprocessing equipment. Disruptions in raw material availability can delay production and increase costs. Limited global suppliers for biotechnological components heighten dependency risks. Transportation bottlenecks and geopolitical uncertainties further strain logistics networks. Companies are increasingly exploring localized production and vertical integration to mitigate these challenges. Without resilient supply chain strategies, scalability and timely commercialization may be constrained.
The COVID-19 pandemic significantly influenced the precision fermentation and cell-cultured food industry. Lockdowns and trade restrictions disrupted research activities, pilot production, and global supply chains. Investment flows slowed temporarily as uncertainty affected funding priorities. However, the pandemic highlighted vulnerabilities in traditional meat supply chains, increasing interest in resilient food systems. Consumer focus on food safety, traceability, and sustainability strengthened the case for alternative proteins. Governments and private investors renewed support for food innovation and biotechnology post-pandemic. As a result, long-term market prospects improved despite short-term operational disruptions.
The cultured meat segment is expected to be the largest during the forecast period
The cultured meat segment is expected to account for the largest market share during the forecast period, due to its close resemblance to conventional animal protein. Cultured meat offers authentic taste, texture, and nutritional profiles without the environmental burden of livestock farming. Increasing investments from food giants and venture capital firms are accelerating product development. Regulatory approvals in select regions are improving market confidence and commercialization prospects. Advances in cell-line development and bioreactor efficiency are enhancing production feasibility. Consumer acceptance is gradually improving as transparency and education increase.
The alternative protein brands segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the alternative protein brands segment is predicted to witness the highest growth rate. Branded companies are actively investing in marketing, product innovation, and consumer engagement. Strong branding helps build trust around novel technologies such as precision fermentation and cultured foods. Direct-to-consumer and foodservice partnerships are expanding brand visibility. Rapid product diversification, including snacks, dairy alternatives, and functional foods, is driving sales growth. Brands are also leveraging sustainability messaging to appeal to younger demographics.
During the forecast period, the North America region is expected to hold the largest market share, due to its strong innovation ecosystem. The region benefits from advanced biotechnology infrastructure and robust R&D investment. The presence of leading startups, research institutions, and established food companies supports rapid commercialization. Favorable funding environments and venture capital activity are accelerating technological breakthroughs. Regulatory agencies are gradually developing frameworks for novel food approvals. High consumer awareness and willingness to adopt alternative proteins further support market leadership.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, owing to rising population and protein demand. Rapid urbanization and income growth are reshaping dietary preferences across the region. Governments are increasingly supporting food security and sustainable protein initiatives. Countries such as China, Singapore, and Japan are investing in cellular agriculture and fermentation technologies. Regulatory progress in select markets is enabling pilot launches and commercialization. Local manufacturers are collaborating with global innovators to accelerate adoption.
Key players in the market
Some of the key players in Precision Fermentation & Cell-Cultured Food Market include Impossible, Perfect Day, Geltor, The EVERY Co, Motif FoodWorks, Imagindairy, Change Foods, New Culture, Eden Brew, Triton Algae Innovations, Remilk, Nature's Fynd, Aleph Farms, SuperMeat, and Vow.
In March 2025, Earthbar in partnership with The EVERY Company, Earthbar is rolling out two Limited Time Offering ("LTO") drinks: the Protein Mocha Latte and Protein Matcha Latte. Each latte packs an impressive 12 to 13 grams of protein per serving without any compromise on taste or texture. The secret ingredient is EVERY's game-changing protein-boosted beverage syrup, featuring EVERY OvoBoost(TM), a highly soluble, highly digestible egg white protein.
In February 2024, Perfect Day has partnered with Unilever's Breyers, a family favorite since 1866, to launch Breyers Lactose-Free Chocolate made with Perfect Day's dairy protein from fermentation. Perfect Day uses a decades-old process of precision fermentation to create its highly functional whey protein that offers the same indulgent experience consumers have loved for decades without any lactose and with a reduced environmental footprint.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.